Health ❯ Healthcare ❯ Patient Care ❯ Treatment Efficacy

Quality of Life

Novartis Breaks Ground on Texas Plant to Speed Radioligand Cancer Drug Delivery

The Denton site extends a $23 billion U.S. buildout designed to place short‑lived therapies closer to patients.

Ianalumab Plus Eltrombopag Extends Disease Control in Phase 3 ITP Study Published in NEJM

CHMP Backs Scemblix Indication Update for Pretreated Ph+ CML in Chronic Phase

Michoacán Commissions Linear Accelerator and PET Scan to Expand Cancer Care